Molecular Imaging in Radiation Oncology (MIRO)
Over the last decade Molecular Imaging with Positron Emission Tomography has emerged as a complementary modality to anatomic imaging methods for better staging and treatment response evaluation in clinical oncology. Fluorodeoxyglucose has been recognized as a universal radiopharmaceutical for many solid tumours. Methionine has proven its value for intracranial tumours and other tracers, such as fluoro-choline, are finding their ways to routine clinical practice. Tracers of hypoxia and proliferation are emerging to characterize the tumour biology and potentially influence the treatment choice. Radiopharmaceuticals for in-vivo monitoring of cell receptors and for unraveling cellular pathways found their way into clinical research and many new tracers are on their way…
Molecular imaging is also being evaluated for its ability to help define target volumes for radiotherapy by introducing the biological component of tumor and normal tissues. Such an approach could potentially lead to delivering a more adequate dose to some part of the target volume, thus paving the way to the concept of “dose painting”.
And this is just the beginning with many more challenges ahead of us!
In this thrilling environment, the European Society for Therapeutic Radiology and Oncology (ESTRO) and the European Association for Nuclear Medicine (EANM) have the pleasure to invite you to participate to the second MOLECULAR IMAGING IN RADIATION ONCOLOGY (MIRO) meeting that will be held in Vienna (AUSTRIA), March 29-31, 2012.
With major emphasis on MULTIDISCIPLINARITY AND INNOVATION, this conference will more specifically cover the following topics:
- Methodological approaches in Molecular Imaging
- Molecular imaging to decipher tumor biology
- New tracers: beyond FDG
- Molecular imaging to personalize treatment in oncology
- State of the art and future prospects in the clinical use of molecular imaging in radiation oncology
- Molecular Imaging radiation dose painting
The format of the conference will combine “state of the art lectures”, lectures on innovative approaches, and proffered papers. Ample time will be given for discussions to allow in-depth interactions among the various disciplines and the participants.
It is hoped that the mix of a rich and challenging scientific programme, and the never ending attraction of the city of Vienna will convince you to attend this conference on MOLECULAR IMAGING IN RADIATION ONCOLOGY.
Prof. Wim Oyen, Netherlands
Prof. Vincent Gregoire, Belgium
Pridruži se diskusiji na forumu
